The global cell isolation market size was estimated to be USD 13.24 billion in 2023 and is expected to reach at USD 50.7 billion by 2033 with a CAGR of 12.98% during the forecast period 2023-2033. Rising government funding for cell-based research, surge in number of patients suffering from cancer & infectious diseases, growing technological advancements, increasing healthcare spending, rising prevalence of chronic diseases, growth in demand for biopharmaceuticals, surge in adoption of advanced technologies such as magnetic cell separation, microfluidics, & flow cytometry, increasing research & development activities, and growing introduction of technologically advanced products in the area of cell isolation or separation are some of the key factors boosting the market growth.
Growing introduction of technologically advanced products in the area of cell isolation or separation is predicted to boost the market growth during the forecast period. For instance, in March 2022, Thermo Fisher Scientific has unveiled the Gibco CTS Xenon Electroporation System, a highly customizable platform designed to facilitate the development and clinical manufacturing of large-scale cell therapies. This system complements Thermo Fisher Scientific's comprehensive range of cell therapy solutions, providing an end-to-end offering.
By Product, Consumables was the highest revenue-grossing segment in the global cell isolation market in 2022 owing to rising usage of consumables in cell isolation procedures, surge in number of regulatory approvals of new consumables, and increasing investment in research for the development of advanced biologics by market players. Additionally, Instruments is predicted to grow at fastest CAGR during the forecast period owing to the rising technological advancements and growing launch of advanced products. For instance, in March 2022, Element Biosciences Inc. has officially introduced the Element AVITI™ System, a compact sequencer that delivers unparalleled performance, cost-effectiveness, and adaptability. By employing Element's exclusive Avidity Sequencing™ chemistries, this system attains exceptional precision and cost-effectiveness, surpassing comparable benchtop systems.
By Cell Type, Animal cells was the highest revenue-grossing segment in the global cell isolation market in 2022 owing to increasing focus on new drug discoveries & development and rising research & development activities. Additionally, Human cell segment is predicted to grow at fastest CAGR during the forecast period owing to the growing focus on human & cancer research, rising favourable reimbursement policies, and increasing introduction of novel products. For instance, in May 2023, Akadeum Life Sciences has launched a new product line, featuring kits for leukopak human immune cell isolation and T-cell activation/expansion, which are specifically designed for cell therapy research and development. This introduction further strengthens the company's existing range of Leukopak cell isolation products.
By Technique, Centrifugation was the highest revenue-grossing segment in the global cell isolation market in 2022 owing to the rising usage of this technique by academic institutes, research laboratories, & biotechnology & biopharmaceutical companies and increasing launch of advanced products. For instance, in October 2022, Thermo Fisher Scientific, Inc. has released DynaCellect, an innovative instrument for cell isolation, activation, and depletion. Additionally, the company has introduced the Dynabeads magnetic beads removal instrument, which enhances the manufacturing process of cell therapy. Additionally, Surface marker is predicted to grow at fastest CAGR during the forecast period owing to the increasing investments in healthcare infrastructure and rising product advancements.
By Application, Biomolecule Isolation was the highest revenue-grossing segment in the global cell isolation market in 2022 owing to increasing launch of advanced products, growing focus on the production of biopharmaceuticals including biosimilar, monoclonal antibodies, & recombinant proteins, rising government funding for new drug development, and surge in launch of technologically advanced products. For instance, in April 2022, Levitas Bio has introduced the LeviCell EOS System, an advanced platform for cell separation. This newly launched product enables precise selection of viable cells and offers a higher throughput compared to the company's current product line. Additionally, Cancer research is predicted to grow at fastest CAGR during the forecast period owing to the growing investment in cell-based research by market players, rising prevalence of cancer, and increasing emergence of precision medicine for cancer treatment.
By End-user, Pharmaceutical & Biotechnology Companies was the highest revenue-grossing segment in the global cell isolation market in 2022 owing to growing investment in research for the development of new products, surge in research & development activities, and rising launch of innovative products by market players. Additionally, Academic & Research Institute is predicted to grow at fastest CAGR during the forecast period owing to the growing research & development initiatives by research institutions, surge in number of research institutes & laboratories. For instance, in April 2022, Curate Biosciences has formed a partnership with the City of Hope, a renowned cancer research and treatment institution in the United States. The collaboration aims to evaluate the efficacy of Curate Biosciences' product, the Curate Cell Processing System, which enables advanced cell separation. The goal is to integrate this platform into the workflow for generating CAR-T cell immunotherapy.
North America region is anticipated for the highest revenue share during the forecast period owing to the growing technological advancements, rising expansion of pharmaceutical & biotechnology industries, increasing prevalence of chronic & infectious diseases, surge in healthcare infrastructure, and growing launch of advanced products. For instance, in August 2022, Cytena has introduced the latest iteration of B.SIGHT, a fully automated single-cell dispenser. This advanced instrument is specifically developed to simplify the process of isolating single cells in microbiology research, with a focus on handling microorganisms such as bacteria and yeast. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the rising healthcare expenditure, surge in research & development activities, growing demand for cell isolation products & services, increasing investment by major market players, and rising introduction of technologically advanced devices. For instance, in January 2022, Sony Corporation has unveiled the CGX10, a novel Cell Isolation System that efficiently and accurately sorts cells within a closed system, ensuring high speed and purity. This technology holds particular significance in areas like cell-based immunotherapy, which is increasingly acknowledged as a promising approach for treating cancer and autoimmune conditions.
Growing introduction of technologically advanced products in the area of cell isolation or separation is predicted to boost the market growth during the forecast period. For instance, in March 2022, Thermo Fisher Scientific has unveiled the Gibco CTS Xenon Electroporation System, a highly customizable platform designed to facilitate the development and clinical manufacturing of large-scale cell therapies. This system complements Thermo Fisher Scientific's comprehensive range of cell therapy solutions, providing an end-to-end offering.
By Product, Consumables was the highest revenue-grossing segment in the global cell isolation market in 2022 owing to rising usage of consumables in cell isolation procedures, surge in number of regulatory approvals of new consumables, and increasing investment in research for the development of advanced biologics by market players. Additionally, Instruments is predicted to grow at fastest CAGR during the forecast period owing to the rising technological advancements and growing launch of advanced products. For instance, in March 2022, Element Biosciences Inc. has officially introduced the Element AVITI™ System, a compact sequencer that delivers unparalleled performance, cost-effectiveness, and adaptability. By employing Element's exclusive Avidity Sequencing™ chemistries, this system attains exceptional precision and cost-effectiveness, surpassing comparable benchtop systems.
By Cell Type, Animal cells was the highest revenue-grossing segment in the global cell isolation market in 2022 owing to increasing focus on new drug discoveries & development and rising research & development activities. Additionally, Human cell segment is predicted to grow at fastest CAGR during the forecast period owing to the growing focus on human & cancer research, rising favourable reimbursement policies, and increasing introduction of novel products. For instance, in May 2023, Akadeum Life Sciences has launched a new product line, featuring kits for leukopak human immune cell isolation and T-cell activation/expansion, which are specifically designed for cell therapy research and development. This introduction further strengthens the company's existing range of Leukopak cell isolation products.
By Technique, Centrifugation was the highest revenue-grossing segment in the global cell isolation market in 2022 owing to the rising usage of this technique by academic institutes, research laboratories, & biotechnology & biopharmaceutical companies and increasing launch of advanced products. For instance, in October 2022, Thermo Fisher Scientific, Inc. has released DynaCellect, an innovative instrument for cell isolation, activation, and depletion. Additionally, the company has introduced the Dynabeads magnetic beads removal instrument, which enhances the manufacturing process of cell therapy. Additionally, Surface marker is predicted to grow at fastest CAGR during the forecast period owing to the increasing investments in healthcare infrastructure and rising product advancements.
By Application, Biomolecule Isolation was the highest revenue-grossing segment in the global cell isolation market in 2022 owing to increasing launch of advanced products, growing focus on the production of biopharmaceuticals including biosimilar, monoclonal antibodies, & recombinant proteins, rising government funding for new drug development, and surge in launch of technologically advanced products. For instance, in April 2022, Levitas Bio has introduced the LeviCell EOS System, an advanced platform for cell separation. This newly launched product enables precise selection of viable cells and offers a higher throughput compared to the company's current product line. Additionally, Cancer research is predicted to grow at fastest CAGR during the forecast period owing to the growing investment in cell-based research by market players, rising prevalence of cancer, and increasing emergence of precision medicine for cancer treatment.
By End-user, Pharmaceutical & Biotechnology Companies was the highest revenue-grossing segment in the global cell isolation market in 2022 owing to growing investment in research for the development of new products, surge in research & development activities, and rising launch of innovative products by market players. Additionally, Academic & Research Institute is predicted to grow at fastest CAGR during the forecast period owing to the growing research & development initiatives by research institutions, surge in number of research institutes & laboratories. For instance, in April 2022, Curate Biosciences has formed a partnership with the City of Hope, a renowned cancer research and treatment institution in the United States. The collaboration aims to evaluate the efficacy of Curate Biosciences' product, the Curate Cell Processing System, which enables advanced cell separation. The goal is to integrate this platform into the workflow for generating CAR-T cell immunotherapy.
North America region is anticipated for the highest revenue share during the forecast period owing to the growing technological advancements, rising expansion of pharmaceutical & biotechnology industries, increasing prevalence of chronic & infectious diseases, surge in healthcare infrastructure, and growing launch of advanced products. For instance, in August 2022, Cytena has introduced the latest iteration of B.SIGHT, a fully automated single-cell dispenser. This advanced instrument is specifically developed to simplify the process of isolating single cells in microbiology research, with a focus on handling microorganisms such as bacteria and yeast. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the rising healthcare expenditure, surge in research & development activities, growing demand for cell isolation products & services, increasing investment by major market players, and rising introduction of technologically advanced devices. For instance, in January 2022, Sony Corporation has unveiled the CGX10, a novel Cell Isolation System that efficiently and accurately sorts cells within a closed system, ensuring high speed and purity. This technology holds particular significance in areas like cell-based immunotherapy, which is increasingly acknowledged as a promising approach for treating cancer and autoimmune conditions.
Segmentation: Cell Isolation Market Report 2022 - 2033
Cell Isolation Market Analysis & Forecast by Product 2022 - 2033 (Revenue USD Bn)
Instruments
- Flow Cytometers
- Filtration Systems
- Centrifuges
- Magnetic-activated Cell Separator Systems
Consumables
- Disposables
- Beads
- Reagents & Kits
Cell Isolation Market Analysis & Forecast by Cell Type 2022 - 2033 (Revenue USD Bn)
- Human Cell
- Animal Cell
Cell Isolation Market Analysis & Forecast by Technique 2022 - 2033 (Revenue USD Bn)
- Centrifugation
- Filtration
- Surface Marker
Cell Isolation Market Analysis & Forecast by Application 2022 - 2033 (Revenue USD Bn)
- Stem Cell Research
- Biomolecule Isolation
- In-vitro Diagnostics
- Cancer Research
- Tissue Regeneration & Regenerative Medicine
- Others
Cell Isolation Market Analysis & Forecast by End-user 2022 - 2033 (Revenue USD Bn)
- Academic & Research Institute
- Pharmaceutical & Biotechnology Companies
- Hospitals & Diagnostic
- Others
Cell Isolation Market Analysis & Forecast by Region 2022 - 2033 (Revenue USD Bn)
North America
- U.S.
- Canada
Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Cell Isolation Market: Product Estimates & Trend Analysis
8. Cell Isolation Market: Cell Type Estimates & Trend Analysis
9. Cell Isolation Market: Technique Estimates & Trend Analysis
10. Cell Isolation Market: Application Estimates & Trend Analysis
11. Cell Isolation Market: End-user Estimates & Trend Analysis
12. Regional Market Analysis
13. North America Cell Isolation Market
14. Europe Global Cell Isolation Market
15. Asia Pacific Global Cell Isolation Market
16. Latin America Global Cell Isolation Market
17. MEA Global Cell Isolation Market
18. Competitor Analysis
19. Company Profiles
Companies Mentioned
- Corning Inc.
- Cytena
- BD
- Danaher
- Terumo Corp.
- Sony Corporation
- GenScript
- Merck KGaA
- Miltenyi Biotec
- Curate Biosciences
- Thermo Fisher Scientific Inc.
- Levitas Bio
- Bio-Rad Laboratories Inc
- STEMCELL Technologies Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 145 |
| Published | August 2023 |
| Forecast Period | 2022 - 2033 |
| Estimated Market Value ( USD | $ 13.24 Billion |
| Forecasted Market Value ( USD | $ 50.7 Billion |
| Compound Annual Growth Rate | 12.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 14 |
